Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

The evolution of controversial new weight loss drugs is shining a spotlight on a crippling, little-understood food phenomenon ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

I'm in London, and I just paid for this damn fat drug I take. I said, it's not working. They said, he said, I just paid $88 ...

New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...

There are some potential downsides though, including misuse by those who do not need to lose weight, some gastric side-effects and in limited cases, potentially pancreatitis and gall bladder disorders ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

GPs across England will, for the first time, be able to prescribe a new weight loss injection on the NHS from Monday, as the ...

Prescription Weight Loss Drugs: Types, Side Effects and How to Choose U.S. News & World Report June 17, 2025, 8:00 PM ...

The NHS have shed light on whether weight loss jab Mounjaro is ready to fight fat in Devon. It comes amid a surge of interest ...